UNLABELLED: Biodistribution data for the radiation synovectomy agent samarium-153-particulate hydroxyapatite (153Sm-PHYP) are reported. METHODS: Mean extra-articular activity accumulation calculated from serial whole-body scans in 13 patients treated for chronic knee synovitis was 0.74% of injected activity (range 0%-3%). RESULTS: In four patients (31%), activity was noted in the lung (mean 0.68% of injected activity). In six patients (46%), 0.29% of injected activity accumulated in the regional lymph nodes and in three patients (23%), 0.62% of injected dose accumulated in the liver. Absorbed dose estimates were lung: 14 mGy, regional lymph nodes; 50 mGy, liver; 4 mGy. SPECT demonstrated good distribution of 153Sm-PHYP throughout the anterior knee compartments, although distribution to the posterior compartment was variable. CONCLUSION: Distribution is dependent on adequate knee flexion immediately following injection and may be influenced by the size range of labeled particles. Favorable biodistribution data suggest that 153Sm-PHYP is a potentially useful radiation synovectomy agent.
UNLABELLED: Biodistribution data for the radiation synovectomy agent samarium-153-particulate hydroxyapatite (153Sm-PHYP) are reported. METHODS: Mean extra-articular activity accumulation calculated from serial whole-body scans in 13 patients treated for chronic knee synovitis was 0.74% of injected activity (range 0%-3%). RESULTS: In four patients (31%), activity was noted in the lung (mean 0.68% of injected activity). In six patients (46%), 0.29% of injected activity accumulated in the regional lymph nodes and in three patients (23%), 0.62% of injected dose accumulated in the liver. Absorbed dose estimates were lung: 14 mGy, regional lymph nodes; 50 mGy, liver; 4 mGy. SPECT demonstrated good distribution of 153Sm-PHYP throughout the anterior knee compartments, although distribution to the posterior compartment was variable. CONCLUSION: Distribution is dependent on adequate knee flexion immediately following injection and may be influenced by the size range of labeled particles. Favorable biodistribution data suggest that 153Sm-PHYP is a potentially useful radiation synovectomy agent.
Authors: Z N Jahangier; F M van der Zant; J W G Jacobs; H G Riedstra; G M M Gommans; J F Verzijlbergen; J W J Bijlsma; J W van Isselt Journal: Ann Rheum Dis Date: 2007-01-12 Impact factor: 19.103
Authors: Yuling Jamie Han; Say Chye Joachim Loo; Ngoc Thao Phung; Hooi Tin Ong; Stephen J Russell; Kah-Whye Peng; Freddy Boey; Jan Ma Journal: J Mater Sci Mater Med Date: 2008-03-25 Impact factor: 3.896
Authors: Ajit S Shinto; K K Kamaleshwaran; Sudipta Chakraborty; K Vyshakh; S G Thirumalaisamy; S Karthik; V N Nagaprabhu; K V Vimalnath; Tapas Das; Sharmila Banerjee Journal: World J Nucl Med Date: 2015 May-Aug
Authors: J U M Calegaro; J Machado; R G Furtado; J S C de Almeida; A V P de Vasconcelos; M F de Barboza; A P de Paula Journal: Haemophilia Date: 2013-12-16 Impact factor: 4.287
Authors: Thomas W Barber; Martin H Cherk; Anne Powell; Kenneth S K Yap; Baki Billah; Victor Kalff Journal: EJNMMI Res Date: 2016-05-31 Impact factor: 3.138
Authors: Eduardo Savio; María Cristina Ures; Patricia Zeledón; Victoria Trindade; Andrea Paolino; Virginia Mockford; Antonio Malanga; Marcelo Fernández; Javier Gaudiano Journal: BMC Nucl Med Date: 2004-01-30